Florida-based biopharmaceutical company Oragenics, Inc. (NYSE: OGEN) (the “Company”) today announced that it has entered into a securities purchase agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE